摘要
20世纪80年代起,淋巴细胞主动免疫诱导母体妊娠期免疫耐受研究的开展,随之而来的原因不明性反复自然流产(unexplained recurrent spontaneous abortion,URSA)患者成功妊娠,无疑为URSA的治疗带来了福音。这个治疗在很长一段时间内也一直是存在争议的话题。随着近年来生殖医学的迅速发展,由免疫因素造成的不孕成为妇产科领域研究的热点。淋巴细胞主动免疫随之拓展到胚胎反复植入失败(recurrent implantation failure,RIF)和不孕症的治疗当中。
In the 1980 s, the development of lymphocyte active immunization inducing maternal pregnancy immune tolerance research, followed by a successful pregnancy of unexplained recurrent spontaneous abortion （URSA） patients, there is no doubt for the treatment of URSA. This treatment has been the subject of debate for a long time. With the rapid development of reproductive medicine in recent years, infertility caused by immune factors have became the hotspot in research of obstetrics and gynecology. Lymphocyte active immunization correspondingly extend to the treatment of embryos recurrent implantation failure （RIF） and infertility.
出处
《中国优生与遗传杂志》
2014年第10期148-150,146,共4页
Chinese Journal of Birth Health & Heredity
基金
广西科学研究与技术开发计划项目
